| Invus Public Equities, L.P. |
5.5% |
3,675,408 |
3,675,408 |
0 |
/s/ Raymond Debbane |
Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner |
|
| Invus Public Equities Advisors, LLC |
5.5% |
3,675,408 |
3,675,408 |
0 |
/s/ Raymond Debbane |
Raymond Debbane, President |
|
| Invus Global Management, LLC |
5.5% |
3,675,408 |
3,675,408 |
0 |
/s/ Raymond Debbane |
Raymond Debbane, President |
|
| Siren, L.L.C. |
5.5% |
3,675,408 |
3,675,408 |
0 |
/s/ Raymond Debbane |
Raymond Debbane, President |
|
| Avicenna Life Sci Master Fund LP |
0.8% |
569,151 |
569,151 |
0 |
/s/ Raymond Debbane |
Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner |
|
| Avicenna Life Sci Master GP LLC |
0.8% |
569,151 |
569,151 |
0 |
/s/ Raymond Debbane |
Raymond Debbane, Chief Executive Officer |
|
| Ulys, L.L.C. |
0.8% |
569,151 |
569,151 |
0 |
/s/ Raymond Debbane |
Raymond Debbane, President |
|
| Raymond Debbane |
6.3% |
4,244,559 |
4,244,559 |
0 |
/s/ Raymond Debbane |
Raymond Debbane |
|